Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

fucosylated umbilical cord blood regulatory T cells

Fucosylated, human umbilical cord blood (UCB)-derived regulatory T cells (Tregs), with potential immunomodulating activity. Ex vivo, Tregs are isolated from cord blood, expanded, and fucosylated. Upon infusion, the fucosylated UCB Tregs modulate immune responses and induce tolerance to allogeneic transplants, such as hematopoietic stem cell transplants (HSCTs). This suppresses graft-versus-host disease (GVHD). Fucosylation improves the activity of Tregs and reduces the amount of Tregs that need to be expanded and infused.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:fucosylated UCB Tregs
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search